Javier Zarranz-Ventura

Sobre mi

Publicacions destacades

• Safety of 6000 intravitreal dexamethasone implants

  Autors:

  Rajesh, Bindu; Zarranz-Ventura, Javier; Fung, Adrian T.; Busch, Catharina; Sahoo, Niroj Kumar;

  (...)

  Sharma, V.; Sarao, Valentina; Chaikitmongkol, Voraporn; Cebeci, Zafer; Ayhan, Ziya;Int Ozurdex Study Grp.

  Veure llistat complet d'autors

  Referència: British Journal Of Ophthalmology 2020.

• Evaluation of Objective Vitritis Grading Method Using Optical Coherence Tomography: Influence of Phakic Status and Previous Vitrectomy

  Autors:

  Zarranz-Ventura, Javier; Keane, Pearse A; Sim, Dawn A; Llorens, Victor; Tufail, Adnan;

  (...)

  Dick, Andrew D; Lee, Richard W; Pavesio, Carlos; Denniston, Alastair K; Adan, Alfredo.

  Veure llistat complet d'autors

  Referència: American Journal Of Ophthalmology 2016.

• Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: Indications, outcomes, and reinjection frequency

  Autors:

  Zarranz-Ventura J; Carreño E; Johnston RL; Mohammed Q; Ross AH;

  (...)

  Pelegrin L; Adan A; Lee RW; Dick AD; Sallam A.

  Veure llistat complet d'autors

  Referència: American Journal Of Ophthalmology 2014.

• The Neovascular Age-Related Macular Degeneration Database Report 2: Incidence, Management, and Visual Outcomes of Second Treated Eyes

  Autors:

  Zarranz-Ventura, Javier; Liew, Gerald; Johnston, Robert L.; Xing, Wen; Akerele, Toks;

  (...)

  Kumar, Vineeth; Tsaloumas, Marie; Mandal, Kaveri; Bunce, Catey; Tufail, Adnan;United Kingdom Age-Related Macular.

  Veure llistat complet d'autors

  Referència: Ophthalmology 2014.

• Characterization of Punctate Inner Choroidopathy Using Enhanced Depth Imaging Optical Coherence Tomography

  Autors:

  Zarranz-Ventura, Javier; Sim, Dawn A; Keane, Pearse A; Patel, Praveen J; Westcott, Mark C;

  Lee, Richard W; Tufail, Adnan; Pavesio, Carlos E.

  Referència: Ophthalmology 2014.

• Phase I Clinical Trial of SYL040012, a Small Interfering RNA Targeting beta-Adrenergic Receptor 2, for Lowering Intraocular Pressure

  Autors:

  Moreno-Montanes, Javier; Sadaba, Belen; Ruz, Veronica; Gomez-Guiu, Almudena; Zarranz, Javier;

  Gonzalez, Maria Victoria; Paneda, Covadonga; Jimenez, Ana Isabel.

  Referència: Molecular Therapy 2014.

• The Effects of Macular Ischemia on Visual Acuity in Diabetic Retinopathy

  Autors:

  Sim, Dawn A; Keane, Pearse A; Zarranz-Ventura, Javier; Fung, Simon; Powner, Michael B;

  (...)

  Bunce, Catey V; Fruttiger, Marcus; Patel, Praveen J; Tufail, Adnan; Egan, Catherine A.

  Veure llistat complet d'autors

  Referència: Investigative Ophthalmology & Visual Science 2013.

• Cirrus High-Definition Optical Coherence Tomography Compared with Stratus Optical Coherence Tomography in Glaucoma Diagnosis

  Autors:

  Moreno-Montanes, Javier; Olmo, Natalia; Alvarez, Aurora; Garcia, Noelia; Zarranz-Ventura, Javier;

  Referència: Investigative Ophthalmology & Visual Science 2010.

• Microplasmin: Ex Vivo Characterization of Its Activity in Porcine Vitreous

  Autors:

  de Smet, Marc D; Valmaggia, Christophe; Zarranz-Ventura, Javier; Willekens, Ben;

  Referència: Investigative Ophthalmology & Visual Science 2009.

Projectes destacats

• Impacto de los factores sistémicos en la red capilar perifoveal evaluada con angiografía por tomografía de coherencia óptica en diabetes mellitus tipo 1

  Investigador/a principal: Javier Zarranz Ventura

  Finançador: Instituto de Salud Carlos III

  Codi: PI18/00518

  Durada: 01/01/2019 - 30/06/2023

• Evaluation of microvascular changes in the perifoveal vascular network using Optical Coherence Tomography Angiography (OCT-A) in type I Diabetes Mellitus

  Investigador/a principal: Javier Zarranz Ventura

  Finançador: Fundació La Marató de TV3

  Codi: TV3_Diabet_16

  Durada: 24/02/2017 - 31/12/2020

• Exploring the impact of treatment delay due to the COVID-19 pandemic on the visual acuity of neovascular age-related macular degeneration patients treated with anti-VEGF therapy

  Investigador/a principal: Javier Zarranz Ventura

  Finançador: Novartis Pharma AG (Basel, Switzerland)

  Codi: FCB-COVIDIVT-2020-02

  Durada: 01/04/2021 - 30/05/2022

• Association between anatomical and clinical outcomes in patients treated with anti-VEGFs for neovascular age-related macular degeneration (nAMD) in the FRB! Registry

  Investigador/a principal: Javier Zarranz Ventura

  Finançador: Novartis Pharma AG (Basel, Switzerland)

  Codi: FCB-TIV-2020-01

  Durada: 01/06/2020 - 30/05/2021

• Desarrollo de sensores nanomecánicos con respuesta cromática para detección rapida de perfiles de citoquinas inflamatorias en Uveítis

  Investigador/a principal: MAR ALVAREZ SANCHEZ

  Finançador: Instituto de Microelectrónica de Barcelona, Centro Nacional de Microelectrónica (IBM-CNM), Centro Superior de Investigaciones Científicas (CSIC) (Sede o evento); Ministerio de Economia y Competitividad. Retos 2015

  Codi: DPI2015-68917-R

  Durada: 01/01/2016 - 31/12/2018